Alpha 2.0
Login Register
» Articles » PMID: 31533876

Molecular-based Tuberculosis Drug Susceptibility Testing: One Size Fits All?

Overview
Journal Int J Tuberc Lung Dis
Specialty Pulmonary Medicine
Date 2019 Sep 20
PMID 31533876
Citations 3
Authors
D Chesov
C Lange
J Heyckendorf
Affiliations
Soon will be listed here.
Citing Articles

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field.

Dookie N, Khan A, Padayatchi N, Naidoo K Front Microbiol. 2022; 13:775030.

PMID: 35401475 PMC: 8988194. DOI: 10.3389/fmicb.2022.775030.

Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making.

Mahomed S, Mlisana K, Cele L, Naidoo K J Clin Tuberc Other Mycobact Dis. 2020; 20:100176.

PMID: 32793816 PMC: 7414011. DOI: 10.1016/j.jctube.2020.100176.

Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing.

Dookie N, Padayatchi N, Lessells R, Naicker C, Chotoo S, Naidoo K Clin Infect Dis. 2020; 71(11):2981-2985.

PMID: 32384148 PMC: 7778351. DOI: 10.1093/cid/ciaa526.